153 related articles for article (PubMed ID: 20184582)
1. Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.
Nosotti L; Francesconi F; Izzi S; Berardesca E; Morrone A; Bonifati C
Br J Dermatol; 2010 Jun; 162(6):1408-10. PubMed ID: 20184582
[No Abstract] [Full Text] [Related]
2. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
3. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
[No Abstract] [Full Text] [Related]
4. Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.
Cassano N; Coviello C; Loconsole F; Miracapillo A; Vena GA
Eur J Dermatol; 2006; 16(3):316-7. PubMed ID: 16709508
[No Abstract] [Full Text] [Related]
5. Acute myelogenous leukemia in a patient receiving etanercept for psoriasis.
Bachmeyer C; Thiolière B; Khosrotehrani K; Cattan E
J Am Acad Dermatol; 2007 Jan; 56(1):169-70. PubMed ID: 17190640
[No Abstract] [Full Text] [Related]
6. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
Gandhi RK; Pickup T; Sheth PB
Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
[No Abstract] [Full Text] [Related]
7. Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.
Antoniou C; Kosmadaki MG; Stratigos AJ; Katsambas AD
Dermatology; 2008; 216(4):364-5. PubMed ID: 18285688
[No Abstract] [Full Text] [Related]
8. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
9. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
Cho YT; Chen CH; Chiu HY; Tsai TF
J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
Girolomoni G; Abeni D
Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
[No Abstract] [Full Text] [Related]
11. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
Carroll MB; Bond MI
Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
[TBL] [Abstract][Full Text] [Related]
12. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
13. Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance.
Prignano F; Ricceri F; Pescitelli L; Bonciani D; Lotti T
Int J Dermatol; 2011 Aug; 50(8):999-1001. PubMed ID: 21781077
[No Abstract] [Full Text] [Related]
14. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
[No Abstract] [Full Text] [Related]
15. QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
Desai N; Raste Y; Cooke NT; Harland CC
Br J Dermatol; 2008 May; 158(5):1137-8. PubMed ID: 18279462
[No Abstract] [Full Text] [Related]
16. Chronic viral hepatitis and TNF-alpha blockade.
Raftery G; Griffiths B; Kay L; Kane D
Rheumatology (Oxford); 2007 Aug; 46(8):1381; author reply 1381-2. PubMed ID: 17567635
[No Abstract] [Full Text] [Related]
17. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
Prestinari F; Ferguglia G; Laria G
Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
19. Etanercept for the treatment of psoriasis.
Bissonnette R
Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
[TBL] [Abstract][Full Text] [Related]
20. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
